LeMaitre Vascular Sees Q1 GAAP EPS $0.64-$0.69 vs $0.61 Est; Sees Sales $65.600M-$67.600M vs $65.855M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q1 GAAP EPS of $0.64-$0.69 vs $0.61 analyst estimate. sees sales of $65.600 million-$67.600 million vs $65.855 million analyst estimate.
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q1 GAAP EPS of $0.64-$0.69 vs $0.61 analyst estimate. sees sales of $65.600 million-$67.600 million vs $65.855 million analyst estimate.